دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Supporting, Not Reporting — Emergency Department Ethics in a Post-Roe Era
Katie Watson, J.D., Maureen Paul, M.D., Susan Yanow, M.S.W., and Jay Baruch, M.D.
doi : 10.1056/NEJMp2209312
Vol. 387 No. 10
Will EMTALA Be There for People with Pregnancy-Related Emergencies?
Sara Rosenbaum, J.D., Alexander Somodevilla, J.D., L.L.M., and Maria Casoni, M.P.H.
doi : 10.1056/NEJMp2209893
Science, Competing Values, and Trade-offs in Public Health — The Example of Covid-19 and Masking
Sarah C. Dupont, M.D., M.P.H., and Sandro Galea, M.D., Dr.P.H.
doi : 10.1056/NEJMp2207670
Open-Source Automated Insulin Delivery in Type 1 Diabetes
Mercedes J. Burnside, M.B., Ch.B., Dana M. Lewis, B.A., Hamish R. Crocket, Ph.D., Renee A. Meier, Ph.D., Jonathan A. Williman, Ph.D., Olivia J. Sanders, R.N., Craig A. Jefferies, M.D., Ann M. Faherty, R.N., Ryan G. Paul, Ph.D., Claire S. Lever, M.N., Sarah K.J. Price, M.N., Carla M. Frewen, R.N.,
doi : 10.1056/NEJMoa2203913
Open-source automated insulin delivery (AID) systems are used by many patients with type 1 diabetes. Data are needed on the efficacy and safety of an open-source AID system.
Closed-Loop Therapy and Preservation of C-Peptide Secretion in Type 1 Diabetes
Charlotte K. Boughton, Ph.D., Janet M. Allen, R.N., Julia Ware, M.D., Malgorzata E. Wilinska, Ph.D., Sara Hartnell, B.Sc., Ajay Thankamony, M.Phil., Tabitha Randell, M.D., Atrayee Ghatak, M.D., Rachel E.J. Besser, Ph.D., Daniela Elleri, Ph.D., Nicola Trevelyan, M.D., Fiona M. Campbell, M.D.,
doi : 10.1056/NEJMoa2203496
Whether improved glucose control with hybrid closed-loop therapy can preserve C-peptide secretion as compared with standard insulin therapy in persons with new-onset type 1 diabetes is unclear.
Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus
Richard A. Furie, M.D., Ronald F. van Vollenhoven, M.D., Kenneth Kalunian, M.D., Sandra Navarra, M.D., Juanita Romero-Diaz, M.D., Victoria P. Werth, M.D., Xiaobi Huang, Ph.D., George Clark, B.S., Hua Carroll, M.D., Adam Meyers, M.S., Cristina Musselli, M.D., Catherine Barbey, Ph.D.,
doi : 10.1056/NEJMoa2118025
Antibody-binding of blood dendritic cell antigen 2 (BDCA2), which is expressed exclusively on plasmacytoid dendritic cells, suppresses the production of type I interferon that is involved in the pathogenesis of systemic lupus erythematosus (SLE). The safety and efficacy of subcutaneous litifilimab, a humanized monoclonal antibody that binds to BDCA2, in patients with SLE have not been extensively studied.
Routine Functional Testing or Standard Care in High-Risk Patients after PCI
Duk-Woo Park, M.D., Do-Yoon Kang, M.D., Jung-Min Ahn, M.D., Sung-Cheol Yun, Ph.D., Yong-Hoon Yoon, M.D., Seung-Ho Hur, M.D., Cheol Hyun Lee, M.D., Won-Jang Kim, M.D., Se Hun Kang, M.D., Chul Soo Park, M.D., Bong-Ki Lee, M.D., Jung-Won Suh, M.D.,
doi : 10.1056/NEJMoa2208335
There are limited data from randomized trials to guide a specific follow-up surveillance approach after myocardial revascularization. Whether a follow-up strategy that includes routine functional testing improves clinical outcomes among high-risk patients who have undergone percutaneous coronary intervention (PCI) is uncertain.
Inhalational Induction
Christopher Conley, M.D., Karolina Brook, M.D., Joseph Louca, M.D., Amy Haber, M.D., Ala Nozari, M.D., Ph.D., and Rafael Ortega, M.D.
doi : 10.1056/NEJMvcm2202144
Arrhythmogenic Right Ventricular Cardiomyopathy
Jocelyn McCullough, D.O., and Rohan G. Perera, M.D.
doi : 10.1056/NEJMicm2119255
Case 27-2022: A 32-Year-Old Man with Confusion, Headache, and Fever
Nagagopal Venna, M.D., Pamela W. Schaefer, M.D., and Eli M. Miloslavsky, M.D.
doi : 10.1056/NEJMcpc2201246
On the Path toward Expanding Treatment Options for Diabetes
Sue A. Brown, M.D.
doi : 10.1056/NEJMe2209840
CLOuDs Disperse — Top-Notch Glucose Control and Residual C-Peptide Secretion
Jan Bolinder, M.D., Ph.D.
doi : 10.1056/NEJMe2209740
Surveillance Stress Testing “POST-PCI� — A Future Class III Recommendation?
Jacqueline E. Tamis-Holland, M.D.
doi : 10.1056/NEJMe2210021
Audio Interview: Rolling Out New Covid-19 Vaccines
Eric J. Rubin, M.D., Ph.D., Lindsey R. Baden, M.D., and Stephen Morrissey, Ph.D.
doi : 10.1056/NEJMe2211875
The Human “Contaminome� and Understanding Infectious Disease
Patricia J. Simner, Ph.D., and Steven L. Salzberg, Ph.D.
doi : 10.1056/NEJMcibr2208625
Race Correction and the X-Ray Machine — The Controversy over Increased Radiation Doses for Black Americans in 1968
Itai Bavli, Ph.D., and David S. Jones, M.D., Ph.D.
doi : 10.1056/NEJMms2206281
Risk of BA.5 Infection among Persons Exposed to Previous SARS-CoV-2 Variants
doi : 10.1056/NEJMc2209479
